Sakar Healthcare per share figures

·UnclassifiedChart ›
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹19.25₹13.70₹7.97₹5.64₹6.59
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹19.25₹13.70₹7.95₹5.63₹6.59
₹145.82₹145.82₹130.06₹120.61₹91.04
₹135.65₹113.14₹80.90₹70.51₹70.04
—₹22.14₹16.22₹11.25₹17.51
₹22.14₹22.14₹1.51−₹16.14−₹25.66
2.22.22.22.21.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SAKAR₹882.80

Sakar Healthcare Limited

· Unclassified
₹ CrorePeersMACPOWERSERVOTECHKAPSTONTHEJOBETAMcap ₹1,964 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS6.595.647.9713.7019.25
Diluted EPS6.595.637.9513.7019.25
Book Value per Share91.04120.61130.06145.82145.82
Revenue per Share70.0470.5180.90113.14135.65
Cash Flow per Share17.5111.2516.2222.14—
Free Cash Flow per Share-25.66-16.141.5122.1422.14
Shares Outstanding (cr)1.92.22.22.22.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.